ExThera Medical Corporation

Device Transactions The device industry pulled in $1.5 billion in financing during the second quarter of 2016, a 15% drop from Q1's $1.8 billion. Once again, debt offerings played a big role, represen

IN VITRO DIAGNOSTICS AccuraGen Inc. AccuraGen raises $40mm through Series B round AccuraGen Inc. (cancer diagnostics) raised $40mm through its Series B round from investors including Junson Ca

New investor Fresenius Medical Care Ventures GmbH is leading a Series B financing round in ExThera Medical Corp. to help fund clinical trials in Germany and the US of the latter’s Seraph Microb

IN VITRO DIAGNOSTICS InSilixa Inc. InSilixa raises $13mm in early-stage round Molecular diagnostics start-up InSilixa Inc. raised $13mm in an early-stage financing led by PointGuard Ventures a